Myocardial Infarction in the Perioperative Setting (MIPS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03837535 |
|
Recruitment Status :
Completed
First Posted : February 12, 2019
Last Update Posted : February 20, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Myocardial Infarction Postoperative Myocardial Injury Intraoperative Complications Intraoperative Hypotension Peroperative Complication | Procedure: Surgery |
Show detailed description
| Study Type : | Observational [Patient Registry] |
| Actual Enrollment : | 400742 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 1 Year |
| Official Title: | Myocardial Infarction in the Perioperative Setting, a Swedish Multi Center Cohort Study |
| Actual Study Start Date : | January 1, 2019 |
| Actual Primary Completion Date : | December 31, 2019 |
| Actual Study Completion Date : | December 31, 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Patients undergoing surgery
Swedish patients, >18 years undergoing surgery 2007-2014
|
Procedure: Surgery
Neuro, Lung/thorax, GI, Gynecologic, Urologic, Orthopedic, Vascular surgery |
- Acute Myocardial Infarction [ Time Frame: Within 30days of the index surgery ]AMI, as detected in the postoperative phase in the electronic medical records or in the Swedeheart registry
- Mortality [ Time Frame: Within 30days of the index surgery and at later predefined time points: 60, 90, 180 and 365 days after the index surgery ]Death, as detected in the postoperative phase in the Swedish cause of death register
- Length of stay (LOS) [ Time Frame: LOS within the year after the index surgery ]Time spent in the hospital (number of days)
- Days at home alive within 30 days (DAH30) [ Time Frame: DAH30 is counted within 30days of the index surgery ]Time spent in the home after the index surgery, takes into account readmissions
- Risk of AMI and Mortality by gender, type of surgery, extent- and recency of comorbidity [ Time Frame: Within one year of the index surgery ]How above mentioned patient characteristics affect risk of AMI and mortality
- Secondary complications [ Time Frame: Secondary complications within one year of the index surgery ]AMI vs non-AMI patients and their risk of AKI, pneumonia, stroke, infections, thromboembolic complications
- Outcomes (AMI+Mortality+Complications) by hospital, region and year [ Time Frame: All outcomes within one year of the index surgery ]All outcomes as affected by hospital type, region and by year
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Adult patients undergoing non-cardiac surgery between 2007 and 2014 in Swedish Hospitals using the Orbit software surgical planning tool. This software system is used in all parts of Sweden and in all types of hospitals (University, County and District hospitals)
- University hospitals: Huddinge, KS, Norrlands universitetssjukhus, MAS, USIL, ** County hospitals: NU-sjukvården, Sundsvalls, Södra Älvsborgs, Örnsköldsviks *** District hospitals: Helsingborgs lasarett, Hässleholms, Kristanstads, Kullbergska, Landskrona, Lycksele, Mälarsjukhuset, Nyköping, Sollefteå, Skellefteå Södertälje, Trelleborg, Ystad, Ängelholm, Privat Ortopedisk klinik
Inclusion Criteria:
- Adults (≥18 years), male and female
- Undergoing elective or non-elective inpatient noncardiac surgery
Exclusion Criteria:
- Cardiac surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03837535
| Sweden | |
| Karolinska University Hospital | |
| Stockholm, Sweden, 17176 | |
| Principal Investigator: | Max Bell, MD, PhD | Karolinska University Hospital, Karolinska Institutet |
| Responsible Party: | Max Bell, MD, PhD, Associate Professor, Senior Lecturer, Karolinska University Hospital |
| ClinicalTrials.gov Identifier: | NCT03837535 |
| Other Study ID Numbers: |
Karolinska UH_PR |
| First Posted: | February 12, 2019 Key Record Dates |
| Last Update Posted: | February 20, 2020 |
| Last Verified: | February 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | De-identified cohort data for primary and secondary endpoints will be shared. |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Analytic Code |
| Time Frame: | Data will be available within a year of study completion |
| Access Criteria: | Data access will be reviewed by an external research committee at the department of perioperative medicine and intensive care at the Karolinska University Hospital |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Myocardial Infarction Hypotension Infarction Intraoperative Complications Ischemia Pathologic Processes |
Necrosis Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |

